DeepMed Research

VRC-FLUMOS0111-00-VP (FluMos-v1)

Generic Name: VRC-FLUMOS0111-00-VP (FluMos-v1)

Clinical Trials

First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults

Phase 1

Completed

Conditions: Influenza
Seasonal Influenza

Interventions: Biological: Flucelvax
Drug: VRC-GENADJ0110-AP-NV (Adjuplex)
Drug: VRC-FLUMOS0111-00-VP (FluMos-v1)

First Posted Date: 2021-05-21

Last Posted Date: 2025-04-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 63

Registration Number: NCT04896086

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy